Tauopathies Treatment Includes the Administration of Several Antidepressant Drugs That Can Treat the Psychopathological or Behavioral Symptoms in Patients

Tauopathies Treatment Market


 Tauopathies treatment is given to people who are going through this condition or other conditions such as Parkinson’s disease, across the globe especially in regions such as the U.S., U.K., and Italy among others. The use of tauopathies treatment is often very limited and varies according to the type and severity of symptoms seen. In milder cases, such as those that affect the temporomandibular joint or TMJ, treatments are not always needed. Tauopathies treatment can be down to surgical means if there is a problem with the jaw structure, such as a deficiency of muscle strength due to muscular weakness in the jaw joint. Suitable treatment with antidepressants may not always be necessary and, in severe cases, may even make the condition worse.

The most common type of tauopathies treatment that doctors recommend for patients with milder forms of the condition is antidepressant treatment. This is usually only recommended in very serious cases where no other treatment can cure or significantly reduce the effects of tauopathies. There are many types of antidepressants and they are classified according to how effectively they treat the patient and their severity of the condition. The two most commonly prescribed antidepressants are for tauopathies treatment are paroxetine (Paxil) and fluoxetine (Prozac). However, some patients do require hospitalization for anxiety or depression that continues after the completion of tauopathies treatment.

Another type of tauopathies treatment that is regularly prescribed is that which uses selective serotonin reuptake inhibitors or SSRIs. These medications, which are sometimes also used in cases of bipolar disorder, increase levels of serotonin in the brain. In many cases, patients will continue to need treatment with antidepressants or other anti-depressants even after completing the tauopathies treatment as they will still have severe symptoms of the disease. Some patients will also need to take levodopa once a day for up to six months before the effects of the drug wear off completely. In regions such as the U.K., the prevalence of tauopathy is high and requires accurate tauopathies treatment. For instance, according to BioMed Central, around 30 million individuals in the region are currently suffering from tauopathy-associated neurological diseases, such as FTDP-17, PD, AD, and many more.

Comments